本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

8.07
-0.2800-3.35%
成交量:14.67萬
成交額:122.60萬
市值:9,871.41萬
市盈率:-2.19
高:8.73
開:8.72
低:7.92
收:8.35
資料載入中...
2024/03/18

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/29

重要事件披露

Form 8-K - Current report
2024/01/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals